Lululemon stock price target lowered to $300 by BofA on macro concerns

BofA Securities reduced its Lululemon (LULU) price target to $300 from $370, yet maintained a Buy rating, viewing the current sub-12x forward P/E valuation as an "all-time low" and a compelling opportunity for a high-margin growth company despite a tougher macro backdrop. The firm, which adjusted its valuation methodology to 20x P/E, anticipates a positive re-rating if LULU meets its Q2 sales growth targets. This contrasts with Morgan Stanley's more cautious stance, which lowered its target to $223 with an Equalweight rating due to concerns over Americas sales trends, even as Lululemon reported a 7% Q1 2025 revenue increase to $2.4 billion.

Analysis

Lululemon Athletica (LULU) is currently at a crossroads, reflected by divergent analyst sentiment despite solid underlying fundamentals. BofA Securities, while reducing its price target to $300 from $370 due to a "tougher macro backdrop," maintains a Buy rating, citing the stock's valuation at an "all-time low" of less than 12 times forward P/E as a compelling opportunity. This bullish case is supported by strong metrics such as a 59.3% gross profit margin, 9.4% revenue growth, and a healthy 2.28 current ratio. BofA suggests a positive re-rating is contingent on the company achieving its 7-8% Q2 sales growth target. In stark contrast, Morgan Stanley has adopted a more cautious stance, lowering its price target to $223 and maintaining an Equalweight rating, primarily due to concerns over the lack of a positive sales trend in the Americas. This mixed outlook comes as Lululemon reported a 7% increase in Q1 revenue to $2.4 billion, indicating steady, albeit not spectacular, performance amidst these headwinds.

Key Decisions for Investors

• Investors with a long-term growth mandate may view the current valuation, which BofA notes is an all-time low on a forward P/E basis, as an attractive entry point for a high-margin business.
• Monitor upcoming Q2 results closely, as the 7-8% sales growth figure is a key catalyst identified by BofA for a potential stock re-rating.
• Be cautious of the persistent weakness in the Americas region, a key risk highlighted by Morgan Stanley that could cap near-term upside potential if it does not show signs of improvement.
• Consider the divergent price targets of $300 (BofA) and $223 (Morgan Stanley) as a proxy for the current bull-bear debate, reflecting uncertainty between fundamental strength and macroeconomic or regional demand pressures.